Novel Drug Evaluated for Familial Chylomicronemia Syndrome
Positive findings from the APPROACH study, which reached its primary end point, and showed the efficacy of volanesorsen therapy for patients with famimlial chylomicronemia syndrome (FCS).
All articles by Lea Eslava-Kim, PharmD
Promising Phase 3 Study Results for Catecholamine Resistant Hypotension Mean Arterial Pressure
A positive phase 3 study showed that patients treated with LJPC-501 were likely to achieve pre-specified blood pressure targets vs placebo.
New Warfarin Formulation Under Review by FDA
A new drug application for warafin potassium has been submitted to the FDA.
- Loading...
Loading...
Next post in CHD
Loading... 
Loading...